Camson Bio Technologies Ltd Initiating Coverage Report By Karvy

Tagged: Camson Bio Technologies, Karvy

This topic has 0 replies, 1 voice, and was last updated 9 years, 8 months ago by Vidhi Khanna.

Viewing 1 post (of 1 total)

Author

Posts
May 4, 2015 at 9:15 pm #2010

Vidhi Khanna
Keymaster

We have valued CBTL by estimating a suitable PE multiple for FY17E EPS, by mapping it to RoE. We have valued the company at 14x of FY17E EPS and reached a per share valuation target of Rs. 189 for an investment horizon of 12 to 18 months. We initiate a coverage on CBTL with a BUY recommendation.

Download Camson Bio Tech IC Karvy
Author

Posts

Viewing 1 post (of 1 total)

You must be logged in to reply to this topic.